Lataa...
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Malignant pleural mesothelioma (MPM) has been marked historically by poor prognosis. Current standard of care for this deadly disease results in sub-optimal improvements in overall survival (OS), which has prompted researchers to explore innovative treatment alternatives. Immunotherapy is an emergin...
Tallennettuna:
| Julkaisussa: | Transl Lung Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5504119/ https://ncbi.nlm.nih.gov/pubmed/28713676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.05.02 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|